{"id":"W2912011158","doi":"10.1158/2326-6074.cricimteatiaacr18-a008","title":"Abstract A008: Neoadjuvant nivolumab, gemcitabine and cisplatin in muscle-invasive bladder cancer: Study update","year":2019,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Genome British Columbia","funders":"","keywords":"Cystectomy; Medicine; Gemcitabine; Bladder cancer; Nivolumab; Oncology; Internal medicine; Cisplatin; Neoadjuvant therapy; Chemotherapy; Urology; Lymph node; Cancer; Immunotherapy; Breast cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004050452,0.0005936911,0.002585525,0.0009046135,0.0002192049,0.001963262,0.0009556481,0.001036337,0.003919282],"category_scores_gemma":[0.004734535,0.0002661871,0.002039469,0.001878963,0.0003137564,0.001052179,0.0006302404,0.001669906,0.0008608519],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008135464,"about_ca_system_score_gemma":0.002131411,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001163596,"about_ca_topic_score_gemma":0.003407049,"domain_scores_codex":[0.9991378,0.0003904551,0.0002070879,0.00008097052,0.0001293409,0.00005435331],"domain_scores_gemma":[0.9954384,0.002189546,0.001050418,0.0001564909,0.0007903685,0.0003747949],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.02998597,0.001217245,0.01734131,0.06282209,0.01162182,0.0002628117,0.0001956242,0.0005813785,0.004577513,0.0006572301,0.0519154,0.8188216],"study_design_scores_gemma":[0.05149299,0.05577103,0.1279577,0.07661907,0.07791159,0.002754287,0.0005721317,0.001296422,0.004203681,0.00198164,0.5992017,0.0002377458],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"review","genre_gemma":"empirical","genre_scores_codex":[0.04368242,0.9336467,0.0009899524,0.005504765,0.001559626,0.001034006,0.004113381,0.0001335283,0.00933554],"genre_scores_gemma":[0.1930235,0.768108,0.003018321,0.01384375,0.004064172,0.00273846,0.01088548,0.000122296,0.004196079],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.004050452,"threshold_uncertainty_score":0.02142107,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05267920487446963,"score_gpt":0.3912411751698508,"score_spread":0.3385619702953812,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}